Searchable abstracts of presentations at key conferences in endocrinology

ea0028p340 | Thyroid | SFEBES2012

Targeted hPTTG overexpression in vivo reduces thyroidal growth and thyroid cell proliferation.

Ryan Gavin , Lewy Gregory , Read Martin , Seed Robert , Sharma Neil , Smith Vicki , Kwan Perkin , Franklyn Jayne , McCabe Christopher , Boelaert Kristien

The human pituitary tumor transforming gene is overexpressed in thyroid cancers; inducing genetic instability through its role as a securin and propagating growth through induction of growth factors. We have demonstrated reduced cellular proliferation following hPTTG overexpression in neuronal cells. We hypothesised targeted hPTTG overexpression in mouse thyroids will result in hyperplastic/neoplastic growth and that stimulation of thyroid cell growth through standard methods ...

ea0019p11 | Bone | SFEBES2009

Impact of body mass index at baseline on parathyroid hormone and phospho-calcium metabolism in adult growth hormone deficient patients before and after growth hormone replacement therapy

Mon Aung , Ahmad Aftab , Malipatil Nagaraj , Joseph Franklin , White Helen , Joshi Ashwin , Sharma Dushyant , Fraser William , Vora Jiten

Background: Adult growth hormone deficient (AGHD) is associated with reduced bone turnover and reduced bone mineral density (BMD): factors improved by growth hormone replacement (GHR). Obesity is associated with reduced bone turnover but increased BMD. We investigated the impact of body mass index on parathyroid hormone (PTH), phospho-calcium metabolism and bone turnover in AGHD patients before and after GHR.Study design: Of 31 AGHD patients (15 obese pa...

ea0073aep120 | Calcium and Bone | ECE2021

An unusual case of primary hyperparathyroidism due to hyperplasia resembling tertiary hyperparathyroidism

Mantega Michele , Mateen Abdul , Azam Sultana , Sharma Bhavna , Seechurn Shivashankar , Remedios Denis , Moonim Mufaddal , DiMarco Aimee , Rahman Mushtaqur

Primary hyperparathyroidism is a common endocrine condition; 80% due to a parathyroid adenoma. We present an unusual case of a 69-year old white European female, who presented first in 2012 with mild hypercalcaemia (< 2.8 mmol/l), osteoporosis, hypertension and type 2 diabetes. Pharmacotherapy included Bendroflumethiazide, but no phosphate supplements. Investigations revealed primary hyperparathyroidism and dual-modality scanning showed no evidence of an adenoma, although ...

ea0094p243 | Neuroendocrinology and Pituitary | SFEBES2023

A rare case of phaeochromocytoma secondary to Phosphatase and Tensin Homolog (PTEN) mutation

Narula Kavita , Lazarus Katharine , Sharma Bhavna , Yang Wei , Alexiadou Kleopatra , Avari Parizad , Hui Elaine , Desouza Bianca , Tan Tricia

A 65-year-old female with PTEN Hamartoma Tumour Syndrome, Follicular thyroid carcinoma, and Endometrial Carcinoma, presented at a tertiary centre due to an asymptomatic adrenal lesion. Previous genetic testing for phaeochromocytoma and paraganglioma in 2020 showed no pathogenic variants in multiple genes (FH, MAX, MEN1, SDHx, SDHAF2, TMEM127, VHL, RET gene). Recent imaging revealed a 9 cm left supra-renal lesion that had been gradually increasing in size since 2010. Plasma nor...

ea0099ep113 | Adrenal and Cardiovascular Endocrinology | ECE2024

Audit of clinical outcomes from our nurse-led adrenal nodule clinic in a London hospital

Efthymiadis Agathoklis , Pua Dannah , Sharma Sangita , Solomon Andrew , Hui Elaine , Seechurn Shivashankar , Rahman Mushtaqur , Qureshi Asjid , Seetho Ian , Deore Mahesh

Introduction: There is an increased number of referrals to endocrinology for adrenal nodules found on imaging. This is due to increased use and advancement in imaging modalities. Adrenal nurse-led clinics are cost-effective and safe. We established an adrenal nodule nurse-led clinic at Northwick Park Hospital in September 2022.Methods: Retrospective data collection and analysis of patients reviewed at the clinic between September 2022-2023.<p class="...

ea0077p162 | Bone and Calcium | SFEBES2021

Undiagnosed probable genetic primary hyperparathyroidism presenting with brown tumors and deafness

Sharma Bhavna , Qureshi Asjid , Rahman Mushtaqar , Tolley Neil , Thakker Rajesh , Hui Elaine , Seechurn Shivshankar , Remedios Denis , Seetho Ian , Deore Mahesh , Mantega Michele , Mateen Abdul

A 25 year old Afghan male presented with a 4 day history of worsening left-sided loin pain. He had a past history of deafness since birth, speech problems and development delay. Bilateral renal calculi and widespread multiple well defined lytic lesions (likely brown tumours) were seen on CT-KUB. The corrected calcium was 3.21 mmols/l, PTH 80 pmol/l, Vitamin D 25 nmol/l, phosphate 0.49 mmols/l, ALP 960 IU/l and fractional calcium excretion was 0.16. His skull X Ray/OPG, done du...

ea0050oc3.6 | Obesity, Diabetes Thyroid | SFEBES2017

Identification of novel sodium iodide symporter interactors which modulate iodide uptake

Fletcher Alice , Poole Vikki , Modasia Bhavika , Imruetaicharoenchoke Waraporn , Thompson Rebecca , Sharma Neil , Nieto Hannah , Baker Katie , Alshahrani Mohammed , Read Martin , Turnell Andrew , Boelaert Kristien , Smith Vicki , McCabe Christopher

By exploiting the canonical function of the sodium iodide symporter (NIS), ablative radioiodide therapy is an effective treatment for thyroid cancer. However, a subset of patients are unable to accumulate sufficient radioiodide due to decreased expression and/or plasma membrane localisation of NIS. Radioiodide therapy has been proposed as a viable treatment for breast cancer, but is hampered by low levels of NIS membrane localisation. Currently, the regulation of NIS trafficki...

ea0050oc3.6 | Obesity, Diabetes Thyroid | SFEBES2017

Identification of novel sodium iodide symporter interactors which modulate iodide uptake

Fletcher Alice , Poole Vikki , Modasia Bhavika , Imruetaicharoenchoke Waraporn , Thompson Rebecca , Sharma Neil , Nieto Hannah , Baker Katie , Alshahrani Mohammed , Read Martin , Turnell Andrew , Boelaert Kristien , Smith Vicki , McCabe Christopher

By exploiting the canonical function of the sodium iodide symporter (NIS), ablative radioiodide therapy is an effective treatment for thyroid cancer. However, a subset of patients are unable to accumulate sufficient radioiodide due to decreased expression and/or plasma membrane localisation of NIS. Radioiodide therapy has been proposed as a viable treatment for breast cancer, but is hampered by low levels of NIS membrane localisation. Currently, the regulation of NIS trafficki...

ea0082p19 | Poster Presentations | SFEEU2022

Amiodarone-induced thyroiditis, complicated by a thyroid storm in a man with Becker Muscular Dystrophy

Rathore Yashasvini Gosavi1, Shadman Ahmed2, Lauren M Quinn2, Neil Sharma2 & Kristien Boelaert2

Section 1: Case history: A 46 year old man with Becker Muscular Dystrophy (BMD), was admitted with palpitations and shortness of breath. He had a past medial history of severe left ventricular dysfunction (LVSD) and cardiac arrhythmias, including atrial fibrillation (AF) treated with amiodarone, and an implantable cardiac defibrillator (ICD) for non-sustained ventricular tachycardia (VT). He had been treated with 3 months of prednisolone for suspected type 2 amiodarone induced...

ea0086p281 | Thyroid | SFEBES2022

The potential interaction between medical treatment and radioiodine treatment success: a systematic review

Zannat Riazul , Lee Jonathan , Muzaffar Jameel , Read Martin L. , Brookes Katie , Sharma Neil , Boelaert Kristien , McCabe Christopher J. , Nieto Hannah T.

Introduction: Radioactive iodine (RAI) therapy is a critical component in the post-surgical management of thyroid cancer patients, as well as being a central therapeutic option in the treatment of hyperthyroidism. Previous work suggests that antithyroid drugs hinder the efficacy of RAI therapy in patients. However, the effects of other background medications on RAI treatment efficacy have not been evaluated. Therefore, we performed a systematic review and metanalysis investiga...